Detailed mode of action of the MTHFD1/2 inhibitor TH9619 now published in Nature Metabolism
The One-carbon Therapeutics team is proud and excited to share
The One-carbon Therapeutics team is proud and excited to share
We are presenting our data at the DDR inhibitor summit,
We look forward to meeting you in person and sharing
Our team is happy and proud to have been voted
CEO Ana Slipicevic present the MTHFD2 program and one-carbon therapeutics
One-carbon therapeutics AB is granted 3,000,000 SEK from Sweden’s innovation agency
We are proud that the MTHFD2 inhibitors are now published
Menu bar